[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.17.16. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
October 20, 2010

Effect of Oral Glucosamine on Pain-Related Disability in Patients With Chronic Low Back Pain

JAMA. 2010;304(15):1673. doi:10.1001/jama.2010.1466

To the Editor: In their randomized placebo-controlled trial, Mr Wilkens and colleagues1 studied the effect of oral glucosamine on pain-related disability in patients with chronic low back pain (LBP). The authors concluded that, in a representative sample of the LBP population presenting in general clinical practice, oral glucosamine did not provide any advantages over placebo for self-administered functional, pain-related, and quality-of-life outcome measures.

First Page Preview View Large
First page PDF preview
First page PDF preview
×